Difference between revisions of "Team:Toulouse France"

Revision as of 19:27, 16 October 2016

iGEM Toulouse 2016

iGEM Toulouse Team presents
Paleotilis, a shield for the Lascaux cave

Back to the origins

What if iGEM stepped 18,000 years back?

At that time, cavemen painted extraordinary frescoes on the Lascaux cave (France). The cave remained stable until its discovery in 1940, which deeply disturbed its ecosystem. It was closed shortly after mainly because of contamination by fungi that cause colored spots on the frescoes. Nowadays, mechanical and chemical solutions are daily used and the cave is still in danger due to their limited efficiency.

At iGEM Toulouse, we thought about an innovative biological solution based on the last advances in synthetic biology. It consists in an engineered Bacillus subtilis bacterium that develops from bacterial organisms present in the cave. It releases antifungals when in close viscinity of fungi. Since we care about our environment, an inducible riboswitch-based double toxin/antitoxin system was created to prevent DNA transmission and a physical device was designed to confine our strain.

Project

The project Paleotilis is composed of three modules: Predation, Antifungals, and Confinement. By following this link you will learn more about these constructions.

Achievements

Bronze medal

Register the team to iGEM, have fun during the summer and attend the Giant Jamboree with smile
Submit successfully the Judging form
Create a page in the wiki with attributions to every people that helped us in different ways
Document a new BioBrick and add it to the registry parts: pSB1C3-OriKan (BBa_K1937002) corresponds to a shuttle vector between E.coli and B.subtilis
Registry (from See Parts)
Create and share a complete description of the team’s project in the Wiki
Attributions: our project could be possible thanks to several persons who helped us in different ways and we are very grateful
Plan to present a beautiful poster and a pleasant Prezi presentation at the Giant Jamboree

Silver medal

Present strong commitment to Human Practices for Science Popularization by participating to different events in France, for Education by developing an education kit, for Safety by minimizing the risk of incidents in the lab and for Ethics by creating a theatre play
Experimentally validate three new BioBricks: pSB1C3-OriKan (BBa_ K1937002), pSB(BS)0K-mini (BBa_ K1937001) and PnagA (BBa_K1937003) worked successfully as expected
Take part to active collaborations for the scientific community: creation of Multilanguage protocol videos thanks to 7 others teams

HP/Silver

Gold medal

Innovative human practices:

-

ExpoScience international

exciting perspectives

-

deep

Ethical reflection

-

Discussions with people

-

Communication with kids

Integrated innovative human practices: integration of discussions with Lascaux Cave experts and deep ethical reflection helped by an ethicist into our project
Improve the function of the existing pSB0K-mini plasmid (Biobrick BBa_K823026), from the 2012 Munich team, in a smaller plasmid pSB0K-mini (Biobrick BBa_ K1937001) and enter it in the Registry
Collaborations:

-

ednfhjzel

-

Imperial College team:

B. subtilis

E. coli

A.L.I.C.E.

HP/Gold

Integrated Pracices

Public Engagement

Website by Team iGEM Toulouse 2016

@@ Line 96: / Line 96: @@
 						<td style="width:50px">
 							<center>
-								<img src="https://static.igem.org/mediawiki/2016/5/5b/Toulouse_France_bronzemedal.jpg" style="width:100%;" />
+								<img src="https://static.igem.org/mediawiki/2016/8/88/Toulouse_France_MedBronze.png" style="width:100%;" />
 							</center>
 						</td>
@@ Line 112: / Line 112: @@
 					<li>Submit successfully <a target="blank" href="https://igem.org/2016_Judging_Form?id=1937"> the Judging form</a></li>
 					<li>Create a page in the wiki with attributions to every people that helped us in different ways</li>
-					<li>Document a new BioBrick and add it to the registry parts: pSB1C3-OriKan (BBa_K1937002) corresponds to a shuttle vector between <i>E.coli</i> and <i>B.subtilis</i>
+					<li>Document a new BioBrick and add it to the registry parts: <a href="http://parts.igem.org/Part:BBa_K1937002">pSB1C3-OriKan (BBa_K1937002)</a> corresponds to a shuttle vector between <i>E.coli</i> and <i>B.subtilis</i>
-					<br>Registry (from <a target="blank" href="https://2016.igem.org/Team:Toulouse_France/Composite_parts"></a>)</li>
+					<br>Registry (from <a target="blank" href="https://2016.igem.org/Team:Toulouse_France/Composite_parts"> See Parts</a>)</li>
 					<li>Create and share a complete description of the team’s project in the Wiki</li>
 					<li><a target="blank" href="https://2016.igem.org/Team:Toulouse_France/Attributions"> Attributions:</a> our project could be
@@ Line 128: / Line 128: @@
 						<td style="width:50px">
 							<center>
-								<img src="https://static.igem.org/mediawiki/2016/1/1d/Toulouse_France_silvermedal.jpg" style="width:100%;" />
+								<img src="https://static.igem.org/mediawiki/2016/1/15/Toulouse_France_MedArgent.png" style="width:100%;" />
 							</center>
 						</td>
@@ Line 146: / Line 146: @@
 					kit, for <b>Safety</b> by minimizing the risk of incidents in the lab and for <b>Ethics</b> by creating
 					a theatre play</li>
-					<li>Experimentally validate three new BioBricks: pSB1C3-OriKan (BBa_ K1937002), pSB(BS)0K-mini (BBa_ K1937001) and PnagA (BBa_K1937003) worked successfully as expected</li>
+					<li>Experimentally validate three new BioBricks: <a href="http://parts.igem.org/Part:BBa_K1937002">pSB1C3-OriKan (BBa_ K1937002)</a>, <a href="http://parts.igem.org/Part:BBa_K1937001">pSB(BS)0K-mini (BBa_ K1937001)</a> and <a href="http://parts.igem.org/Part:BBa_K1937003">PnagA (BBa_K1937003)</a> worked successfully as expected</li>
 					<li>Take part to active collaborations for the scientific community: creation of <b>Multilanguage protocol videos</b> thanks to 7 others teams</li>
 				</ul>
@@ Line 161: / Line 161: @@
 						<td style="width:50px">
 							<center>
-								<img src="https://static.igem.org/mediawiki/2016/3/34/Toulouse_France_goldmedal.jpg" style="width:100%;" />
+								<img src="https://static.igem.org/mediawiki/2016/8/87/Toulouse_France_MedOr.png" style="width:100%;" />
 							</center>
 						</td>
@@ Line 184: / Line 184: @@
 						</ul>
 					<li>Integrated innovative human practices: integration of discussions with Lascaux Cave experts and deep ethical reflection helped by an ethicist into our project</li>
-					<li>Improve the function of the existing pSB0K-mini plasmid (Biobrick BBa_K823026), from the 2012 Munich team, in a smaller plasmid pSB0K-mini (Biobrick BBa_ K1937001) and enter it in the Registry</li>
+					<li>Improve the function of the existing pSB0K-mini plasmid <a href="http://parts.igem.org/Part:BBa_K823026">(Biobrick BBa_K823026)</a>, from the 2012 Munich team, in a smaller plasmid pSB0K-mini <a href="http://parts.igem.org/Part:BBa_K1937001">(Biobrick BBa_ K1937001)</a> and enter it in the Registry</li>
-					<li><a target="blank" href="https://2015.igem.org/Team:Toulouse_France/Collaborations#collab">Collaborations:</a> </li>
+					<li><a target="blank" href="https://2016.igem.org/Team:Toulouse_France/Collaborations">Collaborations:</a> </li>
 					<ul>
 						<strong>-</strong> Myhuyhuiujio <a target="blank" href=""> ednfhjzel <a target="blank" href=""> <br>
-						<strong>-</strong> <a target="blank" href="">Imperial College team:</a> we studied the optimal growth conditions of <i>B. subtilis</i> and <i>E. coli</i> strains to document their software <b>A.L.I.C.E.</b><br>
+						<strong>-</strong> <a target="blank" href="https://2016.igem.org/Team:Imperial_College">Imperial College team:</a> we studied the optimal growth conditions of <i>B. subtilis</i> and <i>E. coli</i> strains to document their software <b>A.L.I.C.E.</b><br>
 					</ul>
 				</ul>
 				<center><a class="button-home" href="https://2016.igem.org/Team:Toulouse_France/HP/Gold" style="border: 1px solid #282828;-webkit-border-radius: 5px;-moz-border-radius: 5px;border-radius: 5px; padding: 5px 15px; color: #282828; text-decoration: none; font-size: 17px; background: none; display: block; width: 200px;">HP/Gold</a></center>
-				<center><a class="button-home" href="https://2016.igem.org/Team:Toulouse_France/Integrated_Pracices" style="border: 1px solid #282828;-webkit-border-radius: 5px;-moz-border-radius: 5px;border-radius: 5px; padding: 5px 15px; color: #282828; text-decoration: none; font-size: 17px; background: none; display: block; width: 200px;">Integrated Pracices</a></center>
+				<center><a class="button-home" href="https://2016.igem.org/Team:Toulouse_France/Integrated_Practices" style="border: 1px solid #282828;-webkit-border-radius: 5px;-moz-border-radius: 5px;border-radius: 5px; padding: 5px 15px; color: #282828; text-decoration: none; font-size: 17px; background: none; display: block; width: 200px;">Integrated Pracices</a></center>
 				<center><a class="button-home" href="https://2016.igem.org/Team:Toulouse_France/Engagement" style="border: 1px solid #282828;-webkit-border-radius: 5px;-moz-border-radius: 5px;border-radius: 5px; padding: 5px 15px; color: #282828; text-decoration: none; font-size: 17px; background: none; display: block; width: 200px;">Public Engagement</a></center>